Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have ...

A study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene ...

Recreational physical activity or lack thereof could be a factor in whether teenage girls develop breast cancer later.

A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.

Join our free daily Horoscope newsletter!

High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell ...

A vitamin A byproduct could weaken the immune system's cancer-fighting ability, according to new Princeton University ...

The deletion of two cancer genes, CHD1 and MAP3K7, improves how well tumors respond to cancer immunotherapy and could be used ...

To get full control of C-CAR031, AZ is buying out AbelZeta's 50% share of the China development and commercialisation rights ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...

The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...